PharmTech Poll Results: Outsourced or In-house? - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

PharmTech Poll Results: Outsourced or In-house?


The question:

If your company uses contract service providers and manufacturers, which function(s) do you typically keep in-house?

Your responses:

  • Discovery research (1 response)
  • Preclinical animal research
  • ADME-tox work
  • Formulation development (1 response)
  • Process development (1 response)
  • Clincial-scale manufacturing through Phase I
  • Clinical-scale manufacturing through Phase II
  • Clinical-scale manufacturing through Phase III
  • Clinical trials
  • Scale-up to commercial manufacturing (2 responses)
  • Commercial-scale manufacturing (2 responses)
  • Fill-finish
  • Other

Do you have any comments on this poll, or would you like to submit your vote? Email us at ptweb@advanstar.com.

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
26%
Oversee medical treatment of patients in the US.
12%
Provide treatment for patients globally.
10%
All of the above.
43%
No government involvement in patient treatment or drug development.
10%
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
FDA Reorganization to Promote Drug Quality
FDA Readies Quality Metrics Measures
New FDA Team to Spur Modern Drug Manufacturing
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?

Click here